Novo Nordisk said it had agreed to license a potential rival to its weight-loss drug Ozempic from a Chinese company. The ...
Delivery apps are allowing Chinese citizens to get their hands on ... is about to start his third month on Ozempic, the brand name that pharmaceutical giant Novo Nordisk gives to semaglutide ...
Novo Nordisk secures global rights (excluding China) for UBT251 in a $2B+ deal with United Biotechnology, advancing obesity ...
The 35-year-old software developer, based in China’s western metropolis of Chengdu, is about to start his third month on Ozempic, the brand name that pharmaceutical giant Novo Nordisk gives to ...